Health Canada - Government of Canada
Skip to left navigationSkip over navigation bars to content
Drugs and Health Products
Need Larger Text?
Contact
MHPD DPSC
Sponsor's document available in PDF format
[accu-chek_aviva_pc-cp_e.pdf]
Pages: 02, Size: 2212 K, Date: 2006-02-01

The Health Products and Food Branch (HPFB) posts on the Health Canada web site safety alerts, public health advisories, press releases and other notices as a service to health professionals, consumers, and other interested parties. These advisories may be prepared with Directorates in the HPFB which includes pre-market and post-market areas as well as market authorization holders and other stakeholders. Although the HPFB grants market authorizations or licenses for therapeutic products, we do not endorse either the product or the company. Any questions regarding product information should be discussed with your health professional.

This is duplicated text of a letter from Roche Diagnostics.
Contact the company for a copy of any references, attachments or enclosures.


PUBLIC COMMUNICATION
Health Canada Endorsed Important Safety Information on
the ACCU-CHEK Aviva Blood Glucose Meter

November 14, 2005

Subject: Important Information on the ACCU-CHEK Aviva Blood Glucose Meter.

Dear valued customer:

With this letter, Roche Diagnostics would like to inform you about a technical corrective action relating to the ACCU-CHEK Aviva blood glucose meter. The action described concerns only this system.

Roche maintains close contact with its customers around the world through its relationships with healthcare professionals as well as through the ACCU-CHEK Customer Care Centers. We have received one single complaint worldwide describing a clearly identifiable, too low and non-plausible blood glucose reading following a measurement performed on the ACCU-CHEK Aviva blood glucose meter. To date, in Canada, we have received no such reports.

The blood glucose meter is equipped with a high performance processor. Studies have shown that in very rare cases a malfunction between the software and the processor can result in an incorrect reading.

Although no cases have occurred in Canada, it cannot be ruled out that individual systems with this malfunction could be in circulation. The only systems that might be affected are those with serial numbers below 526 10 999 999. The serial number is located on the back of the meter (see example).

Accu-Chek Aviva

With regards to these systems, we would like to inform you about methods of quality checking that can be used to identify the malfunction described above:

  • Remove the battery from the rear of the meter and then wait 5 seconds before replacing it. After the battery has been replaced, start the meter with the "ON" button at top right. This will automatically prompt a quality check of the meter. Meters with this fault will not power on.

    If the meter powers "on", you can continue to use your ACCU-CHEK Aviva blood glucose meter in the usual manner.

  • We also invite you to perform a control test per mentioned on page 41 of the Accu-Chek Aviva Owner's Manual whenever your test result does not agree with how you feel, and to remove the battery from the meter again.

If you need assistance, please call the ACCU-CHEK Customer Care Center Monday through Friday; 8:00 a.m. to 8:00 p.m. (ET) at 1-800-363-7949. Meters showing the type of fault described will be replaced immediately free of charge.

The actions described above are being conducted with the knowledge of Health Canada.

Despite the extremely low probability of the case described above, all necessary steps for a technical correction have been implemented.

Roche Diagnostics a division of
Hoffmann-La Roche Limited
201 Boul. Armand-Frappier
Laval, Québec H7V 4A2
Canada
Tel.: (450) 686-7050
Fax: (450) 686-7009

Any suspected adverse reaction can also be reported to:
Health Products and Food Branch Inspectorate
HEALTH CANADA
Address Locator: 2003D
Ottawa, Ontario, K1A 0K9
Tel: The Inspectorate Hotline 1-800-267-9675

The Medical Devices Problem Report Form and the Guidelines can be found on the Health Canada web site.

For other inquiries related to this communication, please contact Health Canada at:
Marketed Health Products Directorate (MHPD)
E-mail: MHPD_DPSC@hc-sc.gc.ca
Tel: (613) 954-6522
Fax: (613) 952-7738

Yours sincerely

original signed by

Tom Roberts
Vice President, Patient Care
Roche Diagnostics (Canada)
Allan Lane, Ph.D.
Director, Regulatory Affairs and Quality Management
Roche Diagnostics (Canada)
Last Updated: 2006-02-01 Top